The Molecular Mechanism of Renal Tubulointerstitial Inflammation Promoting Diabetic Nephropathy

References

• Bonner R, Albajrami O, Hudspeth J, Upadhyay A. Diabetic kidney disease. Primary Care. 2020;47(4):645–659. doi:10.1016/j.pop.2020.08.004
   PubMed Web of Science ®Google Scholar
• Saeedi P, Petersohn I, Salpea P, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the international diabetes federation diabetes Atlas, 9th edition. Diabetes Res Clin Pract. 2019;157:107843. doi:10.1016/j.diabres.2019.107843
   PubMed Web of Science ®Google Scholar
• Parente EB, Harjutsalo V, Forsblom C, Groop PH. The impact of central obesity on the risk of hospitalization or death due to heart failure in type 1 diabetes: a 16-year cohort study. Cardiovasc Diabetol. 2021;20(1):153. doi:10.1186/s12933-021-01340-4
   PubMed Web of Science ®Google Scholar
• Zeni L, Norden A, Cancarini G, Unwin RJ. A more tubulocentric view of diabetic kidney disease. J Nephrol. 2017;30:701–717. doi:10.1007/s40620-017-0423-9
   PubMed Web of Science ®Google Scholar
• Chang DY, Li MR, Yu XJ, Wang SX, Chen M, Zhao MH. Clinical and pathological characteristics of patients with nonproteinuric diabetic nephropathy. Front Endocrinol. 2021;12:761386. doi:10.3389/fendo.2021.761386
   PubMed Web of Science ®Google Scholar
• Vallon V, Thomson SC. The tubular hypothesis of nephron filtration and diabetic kidney disease. Nat Rev Nephrol. 2020;16(6):317–336. doi:10.1038/s41581-020-0256-y
   PubMed Web of Science ®Google Scholar
• Gilbert RE. Proximal tubulopathy: prime mover and key therapeutic target in diabetic kidney disease. Diabetes. 2017;66(4):791–800. doi:10.2337/db16-0796
   PubMed Web of Science ®Google Scholar
• Risdon RA, Sloper JC, De Wardener HE. Relationship between renal function and histological changes found in renal-biopsy specimens from patients with persistent glomerular nephritis. Lancet. 1968;2(7564):363–366. doi:10.1016/s0140-6736(68)90589-8
   PubMed Web of Science ®Google Scholar
• Bohle A, Mackensen-Haen S, von Gise H, et al. The consequences of tubulo-interstitial changes for renal function in glomerulopathies. A morphometric and cytological analysis. Pathol Res Pract. 1990;186(1):135–144. doi:10.1016/s0344-0338(11)81021-6
   PubMed Web of Science ®Google Scholar
• Rodríguez-Iturbe B, García García G. The role of tubulointerstitial inflammation in the progression of chronic renal failure. Nephron Clin Pract. 2010;116(2):c81–88. doi:10.1159/000314656
   PubMedGoogle Scholar
• Habib SL. Kidney atrophy vs hypertrophy in diabetes: which cells are involved? Cell Cycle. 2018;17(14):1683–1687. doi:10.1080/15384101.2018.1496744
   PubMed Web of Science ®Google Scholar
• Kang HM, Ahn SH, Choi P, et al. Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development. Nat Med. 2015;21(1):37–46. doi:10.1038/nm.3762
   PubMed Web of Science ®Google Scholar
• Yao L, Liang X, Qiao Y, Chen B, Wang P, Liu Z. Mitochondrial dysfunction in diabetic tubulopathy. Metabolism. 2022;131:155195. doi:10.1016/j.metabol.2022.155195
   PubMed Web of Science ®Google Scholar
• Yamagishi S, Inagaki Y, Okamoto T, Amano S, Koga K, Takeuchi M. Advanced glycation end products inhibit de novo protein synthesis and induce TGF-β overexpression in proximal tubular cells. Kidney Int. 2003;63(2):464–473. doi:10.1046/j.1523-1755.2003.00752.x
   PubMed Web of Science ®Google Scholar
• Bonventre JV. Can we target tubular damage to prevent renal function decline in diabetes? Semin Nephrol. 2012;32(5):452–462. doi:10.1016/j.semnephrol.2012.07.008
   PubMed Web of Science ®Google Scholar
• Youssef S, Nguyen DT, Soulis T, Panagiotopoulos S, Jerums G, Cooper ME. Effect of diabetes and aminoguanidine therapy on renal advanced glycation end-product binding. Kidney Int. 1999;55(3):907–916. doi:10.1046/j.1523-1755.1999.055003907.x
   PubMed Web of Science ®Google Scholar
• Abbate M, Zoja C, Remuzzi G. How does proteinuria cause progressive renal damage? J Am Soc Nephrol. 2006;17(11):2974–2984. doi:10.1681/asn.2006040377
   PubMed Web of Science ®Google Scholar
• Wolf G, Ziyadeh FN. Cellular and molecular mechanisms of proteinuria in diabetic nephropathy. Neph Physiol. 2007;106(2):26–p31. doi:10.1159/000101797
   Web of Science ®Google Scholar
• Nagata M. Podocyte injury and its consequences. Kidney Int. 2016;89(6):1221–1230. doi:10.1016/j.kint.2016.01.012
   PubMed Web of Science ®Google Scholar
• Mundel P, Shankland SJ. Podocyte biology and response to injury. J Am Soc Nephrol. 2002;13(12):3005–3015. doi:10.1097/01.asn.0000039661.06947.fd
   PubMed Web of Science ®Google Scholar
• Susztak K, Raff AC, Schiffer M, Bottinger EP. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy. Diabetes. 2006;55(1):225–233. doi:10.2337/diabetes.55.01.06.db05-0894
   PubMed Web of Science ®Google Scholar
• Caturano A, D’Angelo M, Mormone A, et al. Oxidative stress in type 2 diabetes: impacts from pathogenesis to lifestyle modifications. Curr Issues Mol Biol. 2023;45(8):6651–6666. doi:10.3390/cimb45080420
   PubMed Web of Science ®Google Scholar
• Pafundi PC, Garofalo C, Galiero R, et al. Role of albuminuria in detecting cardio-renal risk and outcome in diabetic subjects. Diagnostics. 2021;11(2):290. doi:10.3390/diagnostics11020290
   Web of Science ®Google Scholar
• Guthrie RA, Guthrie DW. Pathophysiology of diabetes mellitus. Crit Care Nurs Q. 2004;27(2):113–125. doi:10.1097/00002727-200404000-00003
   PubMedGoogle Scholar
• Matsumoto N, Omagari D, Ushikoshi-Nakayama R, Yamazaki T, Inoue H, Saito I. Hyperglycemia induces generation of reactive oxygen species and accelerates apoptotic cell death in salivary gland cells. Pathobiology. 2021;88(3):234–241. doi:10.1159/000512639
   PubMed Web of Science ®Google Scholar
• Peng J, Li X, Zhang D, et al. Hyperglycemia, p53, and mitochondrial pathway of apoptosis are involved in the susceptibility of diabetic models to ischemic acute kidney injury. Kidney Int. 2015;87(1):137–150. doi:10.1038/ki.2014.226
   PubMed Web of Science ®Google Scholar
• Patschan D, Müller G. Acute kidney injury in diabetes mellitus. Int J Nephrol. 2016;2016:1–7. doi:10.1155/2016/6232909
   Google Scholar
• Khanijou V, Zafari N, Coughlan MT, MacIsaac RJ, Ekinci EI. Review of potential biomarkers of inflammation and kidney injury in diabetic kidney disease. Diabetes Metabol Res Rev. 2022;38(6):e3556. doi:10.1002/dmrr.3556
   PubMed Web of Science ®Google Scholar
• Taniguchi K, Xia L, Goldberg HJ, et al. Inhibition of Src Kinase blocks high glucose-induced EGFR transactivation and collagen synthesis in mesangial cells and prevents diabetic nephropathy in mice. Diabetes. 2013;62(11):3874–3886. doi:10.2337/db12-1010
   PubMed Web of Science ®Google Scholar
• Neumann K, Tiegs G. Immune regulation in renal inflammation. Cell Tissue Res. 2021;385(2):305–322. doi:10.1007/s00441-020-03351-1
   PubMed Web of Science ®Google Scholar
• Ma T, Li X, Zhu Y, et al. Excessive activation of notch signaling in macrophages promote kidney inflammation, fibrosis, and necroptosis. Front Immunol. 2022;13:835879. doi:10.3389/fimmu.2022.835879
   PubMed Web of Science ®Google Scholar
• Yonemoto S, Machiguchi T, Nomura K, Minakata T, Nanno M, Yoshida H. Correlations of tissue macrophages and cytoskeletal protein expression with renal fibrosis in patients with diabetes mellitus. Clin Exper Nephrol. 2006;10(3):186–192. doi:10.1007/s10157-006-0426-7
   PubMedGoogle Scholar
• Tang PM, Nikolic-Paterson DJ, Lan HY. Macrophages: versatile players in renal inflammation and fibrosis. Nat Rev Nephrol. 2019;15(3):144–158. doi:10.1038/s41581-019-0110-2
   PubMed Web of Science ®Google Scholar
• Breda PC, Wiech T, Meyer-Schwesinger C, et al. Renal proximal tubular epithelial cells exert immunomodulatory function by driving inflammatory CD4(+) T cell responses. Am J Physiol Renal Physiol. 2019;317(1):F77–F89. doi:10.1152/ajprenal.00427.2018
   PubMed Web of Science ®Google Scholar
• Dehghanbanadaki H, Forouzanfar K, Kakaei A, et al. The role of CDH2 and MCP-1 mRNAs of blood extracellular vesicles in predicting early-stage diabetic nephropathy. PLoS One. 2022;17(4):e0265619. doi:10.1371/journal.pone.0265619
   PubMed Web of Science ®Google Scholar
• Li RX, Yiu WH, Wu HJ, et al. BMP7 reduces inflammation and oxidative stress in diabetic tubulopathy. Clin Sci. 2015;128(4):269–280. doi:10.1042/cs20140401
   Web of Science ®Google Scholar
• Lu X, Yin D, Zhou B, Li T. MiR-135a promotes inflammatory responses of vascular smooth muscle cells from db/db mice via downregulation of FOXO1. Int Heart J. 2018;59(1):170–179. doi:10.1536/ihj.17-040
   PubMed Web of Science ®Google Scholar
• Du M, Wang Q, Li W, et al. Overexpression of FOXO1 ameliorates the podocyte epithelial-mesenchymal transition induced by high glucose vitro and in vivo. Biochem Biophys Res. 2016;471(4):416–422. doi:10.1016/j.bbrc.2016.02.066
   PubMed Web of Science ®Google Scholar
• Puthanveetil P, Wan A, Rodrigues B. FoxO1 is crucial for sustaining cardiomyocyte metabolism and cell survival. Cardiovasc Res. 2013;97(3):393–403. doi:10.1093/cvr/cvs426
   PubMed Web of Science ®Google Scholar
• Xing YQ, Li A, Yang Y, Li XX, Zhang LN, Guo HC. The regulation of FOXO1 and its role in disease progression. Life Sci. 2018;193:124–131. doi:10.1016/j.lfs.2017.11.030
   PubMed Web of Science ®Google Scholar
• Sun H, Shao X, He J, Golos M, Shi B. Role of the mTOR‑FOXO1 pathway in obesity‑associated renal tubulointerstitial inflammation. Mol Med Rep. 2019;19(2):1284–1293. doi:10.3892/mmr.2018.9727
   PubMed Web of Science ®Google Scholar
• Chen J, Xiao H, Xue R, et al. Nicotine exacerbates diabetic nephropathy through upregulation of Grem1 expression. Mol Med. 2023;29(1):92. doi:10.1186/s10020-023-00692-9
   PubMed Web of Science ®Google Scholar
• Vallon V, Thomson SC. Renal function in diabetic disease models: the tubular system in the pathophysiology of the diabetic kidney. Annu Rev Physiol. 2012;74:351–375. doi:10.1146/annurev-physiol-020911-153333
   PubMed Web of Science ®Google Scholar
• Weston CE, Feibelman MB, Wu K, Simon EE. Effects of EGF and IGF-1 on proliferation of cultured human proximal tubule cells after oxidant stress. Renal Failure. 2004;26(1):13–20. doi:10.1081/JDI-120028538
   PubMed Web of Science ®Google Scholar
• Jo HA, Kim JY, Yang SH, et al. The role of local IL6/JAK2/STAT3 signaling in high glucose-induced podocyte hypertrophy. Kidney Res Clin Pract. 2016;35(4):212–218. doi:10.1016/j.krcp.2016.09.003
   PubMedGoogle Scholar
• Ridker PM. From C-reactive protein to interleukin-6 to interleukin-1: moving upstream to identify novel targets for atheroprotection. Circ Res. 2016;118(1):145–156. doi:10.1161/circresaha.115.306656
   PubMed Web of Science ®Google Scholar
• Li H, Wang J, Liu X, Cheng Q. MicroRNA-204-5p suppresses IL6-mediated inflammatory response and chemokine generation in HK-2 renal tubular epithelial cells by targeting IL6R. Biochem Cell Biol. 2019;97(2):109–117. doi:10.1139/bcb-2018-0141
   PubMedGoogle Scholar
• Speeckaert MM, Speeckaert R, Laute M, Vanholder R, Delanghe JR. Tumor necrosis factor receptors: biology and therapeutic potential in kidney diseases. Am J Nephrol. 2012;36(3):261–270. doi:10.1159/000342333
   PubMed Web of Science ®Google Scholar
• Wang J, Feng Y, Zhang Y, et al. TNF-α and IL-1β promote renal podocyte injury in T2DM rats by decreasing glomerular VEGF/eNOS expression levels and altering hemodynamic parameters. J Inflamm Res. 2022;15:6657–6673. doi:10.2147/jir.S391473
   PubMed Web of Science ®Google Scholar
• Lampropoulou IT, Stangou Μ, Sarafidis P, et al. TNF-α pathway and T-cell immunity are activated early during the development of diabetic nephropathy in type II diabetes mellitus. Clin Immunol. 2020;215:108423. doi:10.1016/j.clim.2020.108423
   PubMed Web of Science ®Google Scholar
• Baud L, Ardaillou R. Tumor necrosis factor in renal injury. Mineral Electrol Metabol. 1995;21(4–5):336–341. doi:10.1016/S0344-0338(11)81021-6
   PubMedGoogle Scholar
• Omote K, Gohda T, Murakoshi M, et al. Role of the TNF pathway in the progression of diabetic nephropathy in KK-A(y) mice. Am J Physiol Renal Physiol. 2014;306(11):F1335–F1347. doi:10.1152/ajprenal.00509.2013
   PubMed Web of Science ®Google Scholar
• Chen TK, Coca SG, Estrella MM, et al. Longitudinal TNFR1 and TNFR2 and kidney outcomes: results from AASK and VA NEPHRON-D. J Am Soc Nephrol. 2022;33(5):996–1010. doi:10.1681/asn.2021060735
   PubMed Web of Science ®Google Scholar
• Szeto HH. Pharmacologic approaches to improve mitochondrial function in AKI and CKD. J Am Soc Nephrol. 2017;28(10):2856–2865. doi:10.1681/asn.2017030247
   PubMed Web of Science ®Google Scholar
• Chung KW, Dhillon P, Huang S, et al. Mitochondrial damage and activation of the STING pathway lead to renal inflammation and fibrosis. Cell Metab. 2019;30(4):784–799.e785. doi:10.1016/j.cmet.2019.08.003
   PubMed Web of Science ®Google Scholar
• Yu EP, Bennett MR. The role of mitochondrial DNA damage in the development of atherosclerosis. Free Rad Biol Med. 2016;100:223–230. doi:10.1016/j.freeradbiomed.2016.06.011
   PubMed Web of Science ®Google Scholar
• Lindblom R, Higgins G, Coughlan M, de Haan JB. Targeting mitochondria and reactive oxygen species-driven pathogenesis in diabetic nephropathy. Rev Diabet Stud. 2015;12(1–2):134–156. doi:10.1900/rds.2015.12.134
   PubMedGoogle Scholar
• Takagi S, Li J, Takagaki Y, et al. Ipragliflozin improves mitochondrial abnormalities in renal tubules induced by a high-fat diet. J Diabetes Investig. 2018;9(5):1025–1032. doi:10.1111/jdi.12802
   PubMed Web of Science ®Google Scholar
• Lee SE, Jang JE, Kim HS, et al. Mesenchymal stem cells prevent the progression of diabetic nephropathy by improving mitochondrial function in tubular epithelial cells. Exp. Mol. Med. 2019;51(7):1–14. doi:10.1038/s12276-019-0268-5
   Google Scholar
• Tang SCW, Yiu WH. Innate immunity in diabetic kidney disease. Nat Rev Nephrol. 2020;16(4):206–222. doi:10.1038/s41581-019-0234-4
   PubMed Web of Science ®Google Scholar
• Zhu Y, Huang G, Yang Y, et al. Chinese herbal medicine Suyin detoxification granule inhibits pyroptosis and epithelial-mesenchymal transition by downregulating MAVS/NLRP3 to alleviate renal injury. J Inflamm Res. 2021;14:6601–6618. doi:10.2147/jir.S341598
   PubMed Web of Science ®Google Scholar
• Guo H, Bi X, Zhou P, Zhu S, Ding W. NLRP3 Deficiency attenuates renal fibrosis and ameliorates mitochondrial dysfunction in a mouse unilateral ureteral obstruction model of chronic kidney disease. Mediators Inflamm. 2017;2017:8316560. doi:10.1155/2017/8316560
   PubMed Web of Science ®Google Scholar
• Qi R, Yang C. Renal tubular epithelial cells: the neglected mediator of tubulointerstitial fibrosis after injury. Cell Death Dis. 2018;9(11):1126. doi:10.1038/s41419-018-1157-x
   PubMed Web of Science ®Google Scholar
• Tang SC, Chan LY, Leung JC, et al. Bradykinin and high glucose promote renal tubular inflammation. Nephrol Dial Transplant. 2010;25(3):698–710. doi:10.1093/ndt/gfp599
   PubMed Web of Science ®Google Scholar
• de Haij S, Adcock IM, Bakker AC, Gobin SJ, Daha MR, van Kooten C. Steroid responsiveness of renal epithelial cells. Dissociation of transrepression and transactivation. J Biol Chem. 2003;278(7):5091–5098. doi:10.1074/jbc.M209836200
   PubMed Web of Science ®Google Scholar
• Ren Q, Guo F, Tao S, Huang R, Ma L, Fu P. Flavonoid fisetin alleviates kidney inflammation and apoptosis via inhibiting Src-mediated NF-κB p65 and MAPK signaling pathways in septic AKI mice. Biomed. Pharmacother. 2020;122:109772. doi:10.1016/j.biopha.2019.109772
   PubMed Web of Science ®Google Scholar
• Zhang J, Gu C, Lawrence DA, Cheung AK, Huang Y. A plasminogen activator inhibitor type 1 mutant retards diabetic nephropathy in db/db mice by protecting podocytes. Exp Physiol. 2014;99(5):802–815. doi:10.1113/expphysiol.2013.077610
   PubMed Web of Science ®Google Scholar
• Lupachyk S, Watcho P, Stavniichuk R, Shevalye H, Obrosova IG. Endoplasmic reticulum stress plays a key role in the pathogenesis of diabetic peripheral neuropathy. Diabetes. 2013;62(3):944–952. doi:10.2337/db12-0716
   PubMed Web of Science ®Google Scholar
• Leng YP, Qiu N, Fang WJ, Zhang M, He ZM, Xiong Y. Involvement of increased endogenous asymmetric dimethylarginine in the hepatic endoplasmic reticulum stress of type 2 diabetic rats. PLoS One. 2014;9(2):e97125. doi:10.1371/journal.pone.0097125
   PubMedGoogle Scholar
• Li F, Chen Y, Li Y, Huang M, Zhao W. Geniposide alleviates diabetic nephropathy of mice through AMPK/SIRT1/NF-κB pathway. Eur J Pharmacol. 2020;886:173449. doi:10.1016/j.ejphar.2020.173449
   PubMed Web of Science ®Google Scholar
• Qu X, Zhai B, Liu Y, et al. Pyrroloquinoline quinone ameliorates renal fibrosis in diabetic nephropathy by inhibiting the pyroptosis pathway in C57BL/6 mice and human kidney 2 cells. Biomed. Pharmacother. 2022;150:112998. doi:10.1016/j.biopha.2022.112998
   PubMed Web of Science ®Google Scholar
• Hodgkins KS, Schnaper HW. Tubulointerstitial injury and the progression of chronic kidney disease. Pediatr Nephrol. 2012;27(6):901–909. doi:10.1007/s00467-011-1992-9
   PubMed Web of Science ®Google Scholar
• Zhang L, Xu C, Hu W, Wu P, Qin C, Zhang J. Anti-inflammatory effects of Lefty-1 in renal tubulointerstitial inflammation via regulation of the NF-κB pathway. Int J Mol Med. 2018;41(3):1293–1304. doi:10.3892/ijmm.2017.3327
   PubMed Web of Science ®Google Scholar
• Li H, Duann P, Li Z, et al. The cell membrane repair protein MG53 modulates transcription factor NF-κB signaling to control kidney fibrosis. Kidney Int. 2022;101(1):119–130. doi:10.1016/j.kint.2021.09.027
   PubMed Web of Science ®Google Scholar
• Maik-Rachline G, Zehorai E, Hanoch T, Blenis J, Seger R. The nuclear translocation of the kinases p38 and JNK promotes inflammation-induced cancer. Sci Signal. 2018;11(525). doi:10.1126/scisignal.aao3428
   PubMed Web of Science ®Google Scholar
• Wu Q, Wu W, Fu B, Shi L, Wang X, Kuca K. JNK signaling in cancer cell survival. Med Res Rev. 2019;39(6):2082–2104. doi:10.1002/med.21574
   PubMed Web of Science ®Google Scholar
• Song Q, Xiang TY, Jian-Mei XU, Liu JG, Gao P. Effect of donglian capsules on protein expression of p38MAPK,CREB1 and TGFβ1 in diabetic nephropathy model rats induced by streptozotocin. Inform Trad Chin Med. 2016;33(1):1–5. doi:10.19656/j.cnki.1002-2406.2016.01.001
   Google Scholar
• Wang SY, Gao K, Deng DL, et al. TLE4 promotes colorectal cancer progression through activation of JNK/c-Jun signaling pathway. Oncotarget. 2016;7(3):2878–2888. doi:10.18632/oncotarget.6694
   PubMedGoogle Scholar
• Ma L, Wu F, Shao Q, Chen G, Xu L, Lu F. Baicalin alleviates oxidative stress and inflammation in diabetic nephropathy via Nrf2 and MAPK signaling pathway. Drug Des Devel Ther. 2021;15:3207–3221. doi:10.2147/dddt.S319260
   PubMed Web of Science ®Google Scholar
• Wang Y, Fang Q, Jin Y, et al. Blockade of myeloid differentiation 2 attenuates diabetic nephropathy by reducing activation of the renin-angiotensin system in mouse kidneys. Br J Pharmacol. 2019;176(14):2642–2657. doi:10.1111/bph.14687
   PubMed Web of Science ®Google Scholar
• Shen S, Huang J, Xu C, et al. ERK modulates macrophage polarization and alters exosome miRNA expression in diabetic nephropathy. Clin Lab. 2021;67(12). doi:10.7754/Clin.Lab.2021.210314
   Web of Science ®Google Scholar
• Wang K, Wu YG, Su J, Zhang JJ, Zhang P, Qi XM. Total glucosides of paeony regulates JAK2/STAT3 activation and macrophage proliferation in diabetic rat kidneys. Am J Chin Med. 2012;40(3):521–536. doi:10.1142/s0192415x12500401
   PubMed Web of Science ®Google Scholar
• Yang Y, Lei Y, Liang Y, et al. Vitamin D protects glomerular mesangial cells from high glucose-induced injury by repressing JAK/STAT signaling. Int Urol Nephrol. 2021;53(6):1247–1254. doi:10.1007/s11255-020-02728-z
   PubMed Web of Science ®Google Scholar
• Yang L, Xue J, Meng X, Wang Y, Bai Y. Effects of total flavonoids from Oxytropis falcata Bunge on the SOCS/JAK/STAT inflammatory signaling pathway in the kidneys of diabetic nephropathy model mice. Eur J Inflammation. 2019;17(2):205873921986187. doi:10.1177/2058739219861877
   Google Scholar
• Hu J, Fan X, Meng X, Wang Y, Liang Q, Luo G. Evidence for the involvement of JAK/STAT/SOCS pathway in the mechanism of Tangshen formula-treated diabetic nephropathy. Planta Med. 2014;80(8–9):614–621. doi:10.1055/s-0034-1368454
   PubMed Web of Science ®Google Scholar
• Li J, Yang Y, Wei S, et al. Corrigendum: bixin protects against kidney interstitial fibrosis through promoting STAT6 degradation. Front Cell Dev Biol. 2020;8:643207. doi:10.3389/fcell.2020.643207
   PubMed Web of Science ®Google Scholar
• Johnson DE, Ra O, Grandis JR. Targeting the IL-6/JAK/STAT3 signalling axis in cancer. Nat Rev Clin Oncol. 2018;15(4):234–248. doi:10.1038/nrclinonc.2018.8
   PubMed Web of Science ®Google Scholar
• Chen W, Yuan H, Cao W, et al. Blocking interleukin-6 trans-signaling protects against renal fibrosis by suppressing STAT3 activation. Theranostics. 2019;9(14):3980–3991. doi:10.7150/thno.32352
   PubMed Web of Science ®Google Scholar
• Liau NPD, Laktyushin A, Lucet IS, et al. The molecular basis of JAK/STAT inhibition by SOCS1. Nat Commun. 2018;9(1):1558. doi:10.1038/s41467-018-04013-1
   PubMedGoogle Scholar
• Zhang H, Zhang S, Wang L, Liu X, Wu Y. Chitooligosaccharide guanidine inhibits high glucose-induced activation of DAG/PKC pathway by regulating expression of GLUT2 in type 2 diabetic nephropathy rats. J Func Food. 2018;41:41–47. doi:10.1016/j.jff.2017.12.032
   Web of Science ®Google Scholar
• Suji G, Sivakami S. DNA damage by free radical production by aminoguanidine. Ann N Y Acad Sci. 2006;1067:191–199. doi:10.1196/annals.1354.023
   PubMed Web of Science ®Google Scholar
• Noh H, King GL. The role of protein kinase C activation in diabetic nephropathy. Kidney Int Suppl. 2007;(106):S49–53. doi:10.1038/sj.ki.5002386
   PubMedGoogle Scholar
• Yang Y, Liu S, Wang P, et al. DNA-dependent protein kinase catalytic subunit (DNA-PKcs) drives chronic kidney disease progression in male mice. Nat Commun. 2023;14(1):1334. doi:10.1038/s41467-023-37043-5
   PubMed Web of Science ®Google Scholar
• Meier M, Menne J, Park JK, et al. Deletion of protein kinase C-epsilon signaling pathway induces glomerulosclerosis and tubulointerstitial fibrosis in vivo. J Am Soc Nephrol. 2007;18(4):1190–1198. doi:10.1681/asn.2005070694
   PubMed Web of Science ®Google Scholar
• Sagoo MK, Gnudi L. Diabetic nephropathy: is there a role for oxidative stress? Free Rad Biol Med. 2018;116:50–63. doi:10.1016/j.freeradbiomed.2017.12.040
   PubMed Web of Science ®Google Scholar
• Lim AK, Nikolic-Paterson DJ, Ma FY, et al. Role of MKK3-p38 MAPK signalling in the development of type 2 diabetes and renal injury in obese db/db mice. Diabetologia. 2009;52(2):347–358. doi:10.1007/s00125-008-1215-5
   PubMed Web of Science ®Google Scholar
• Ding W, Wang F, Fang Q, Zhang M, Chen J, Gu Y. Association between two genetic polymorphisms of the renin-angiotensin-aldosterone system and diabetic nephropathy: a meta-analysis. Mol Biol Rep. 2012;39(2):1293–1303. doi:10.1007/s11033-011-0862-7
   PubMed Web of Science ®Google Scholar
• Rodríguez-Iturbe B, Johnson RR, Herrera-Acosta J. Tubulointerstitial damage and progression of renal failure. Kidney Int Suppl. 2005;(99):S82–S86. doi:10.1111/j.1523-1755.2005.09915.x
   PubMedGoogle Scholar